Previous 10 | Next 10 |
2024-06-16 10:38:06 ET Summary Avadel Pharmaceuticals is a small-cap biopharma company headquartered in Dublin, Ireland. The company's primary asset is LUMRYX, which has the potential to be a 'best of breed' compound in a large market. Currently, Avadel is locked in a pivotal ...
2024-06-14 06:13:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips If this year’s market volatility has left you reeling, you’re not alone. But, despite the high valuations plaguing many tech stocks , plenty of top-tier, high-quality blue-c...
2024-06-12 18:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-05 11:34:16 ET More on Jazz Pharmaceuticals Jazz Pharmaceuticals plc (JAZZ) Q1 2024 Earnings Call Transcript Jazz Pharmaceuticals plc 2024 Q1 - Results - Earnings Call Presentation Jazz Pharmaceuticals: Cheap But Complicated Jazz presents additional p...
2024-06-05 05:00:07 ET Andrea Tan from Goldman Sachs issued a price target of $169.00 for JAZZ on 2024-06-05 02:23:00. The adjusted price target was set to $169.00. At the time of the announcement, JAZZ was trading at $104.48. The overall price target consensus is at $20...
2024-06-01 17:13:06 ET More on Jazz Pharmaceuticals Jazz Pharmaceuticals: Cheap But Complicated Avadel gains for a second day as analysts see it prevailing in case vs Jazz/FDA Avadel Pharma gains during hearing over dispute on FDA approval of a sleep disorder drug (u...
Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 PR Newswire Zanidatamab demonstrated a median overall survival (OS) of 15.5 month...
Jazz Pharmaceuticals Showcases Pioneering Research in Sleep Medicine at SLEEP 2024 PR Newswire Thirteen abstracts, including five late-breaking abstracts, underscore Jazz's ongoing commitment to advancing the understanding and treatment of serious sleep disorders Oral ...
Jazz Pharmaceuticals to Participate in Upcoming June Investor Conferences PR Newswire DUBLIN , May 29, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Company management will participate in the following investor conferences...
Zanidatamab Granted Priority Review for HER2-Positive Metastatic Biliary Tract Cancer PR Newswire Target Action (PDUFA) Date set for November 29, 2024 If approved, zanidatamab will be the first HER2-targeted treatment specifically indicated for patients with HER2+ ...
News, Short Squeeze, Breakout and More Instantly...
Jazz Pharmaceuticals plc Company Name:
JAZZ Stock Symbol:
NASDAQ Market:
Jazz Pharmaceuticals plc Website:
Jazz Pharmaceuticals Announces Successful Completion of Term Loan Repricing and Irrevocable Election of Settlement Method for the 2.000% Exchangeable Senior Notes due 2026 PR Newswire DUBLIN , July 22, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) ...
Jazz Pharmaceuticals to Report 2024 Second Quarter Financial Results on July 31, 2024 PR Newswire DUBLIN , July 17, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2024 second quarter financial results on Wed...